Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the State Health Insurance Fund topic
No spam. Unsubscribe anytime.
Lawmakers warned HIDIF cash balance could run out; executive proposes large one‑time subsidy and a $25M ongoing deposit
Summary
JLBC and ADOA briefed the committee that the Health Insurance Trust Fund (HIDIF) has required repeated one‑time employer subsidies in recent years and that the executive proposes a $198M one‑time FY26 employer subsidy plus a $25M ongoing GF deposit to stabilize the fund.
JLBC and ADOA officials told the House Appropriations Committee on Feb. 5 that Arizona’s self‑insured state employee health plan (HIDIF) has run repeated shortfalls and may hit critically low balances in FY26 unless the Legislature and governor act.
Chandler Korner of JLBC told the committee HIDIF has received multiple one‑time employer premium subsidies since FY18 to stabilize the trust. Those deposits have totaled hundreds of millions of dollars, Korner said, and the executive’s FY26 budget proposes a $198 million one‑time employer subsidy (about $423 million total funds) plus a $25 million ongoing general‑fund deposit for HIDIF.
Korner said plan expenditures spiked in FY24 and remain elevated: “State plan expenditures, as we just saw, grew by 15% in FY '24,” he told lawmakers, and the executive assumes continued double‑digit growth in its FY26 projection. JLBC staff reported year‑to‑date FY25 expenditures were about 13.2% above the prior year over the same period. The staff highlighted pharmacy spending as a major driver, including the new class of high‑cost GLP‑1 and other specialty drugs.
ADOA’s Jacob Wingate told the panel the agency has a pharmacist on staff and is conducting procurements and audits intended to control pharmacy costs; Paul Shannon, ADOA benefits director, described contracting and rebate complexities and called the PBM industry “an opaque industry.” Shannon said ADOA’s recent work to audit pharmacy rebates and contracts produced recoveries and business‑intelligence improvements; ADOA reported several million dollars of additional rebate recoveries over the last three years tied to contract and audit work.
JLBC flagged two other issues: (1) how the executive reallocated the proposed one‑time subsidy among agencies (JLBC said some universities and other units would receive very different proportionate increases under the executive’s rebasing); and (2) whether HIDIF needed a larger ongoing reserve. Korner noted typical cash balances have ranged and that the executive proposed budgeting a $100 million HIDIF ending balance, higher than some prior practice.
Korner told the committee a structural risk remains: "Without funding HIDIF's cash balance could hit $0 by August 2025," referencing daily cash‑flow volatility the staff displayed in charts. Committee members asked for longer‑range cash projections, the detail behind executive reallocations among agencies, and more precise estimates of how different expenditure growth rates would change FY26 funding needs.
Why this matters: HIDIF funds benefits for roughly 136,000 members (employees, dependents and retirees). A trust‑fund failure would disrupt coverage for a large population and affect state employer payroll costs, tuition/tax flows for universities and agency budgets. Committee staff and ADOA described procurement and audit efforts to manage pharmacy costs; lawmakers requested additional modeling and documentation before approving FY26 stabilization funding.
